Skip to main
THC

Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare (THC) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 39%
Buy 56%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Tenet Healthcare is well-positioned in the healthcare industry as one of the largest acute-care hospital operators in the US with 50 hospitals and over 380 ambulatory surgery centers. The company's 1Q26 results showed solid revenue growth despite winter weather challenges, with growth expected to continue as management raised their adjusted EPS outlook for the year. Risks to the positive outlook include potential headwinds from the loss of HIX eAPTCs and declining high-acuity volumes, but the company's strong operational discipline and continued growth in the USPI segment make it an attractive long-term investment opportunity.

Bears say

Tenet Healthcare is facing numerous challenges in the current healthcare landscape, including potential changes in healthcare policies and regulations, reduced government funding, and challenges with its hospital and ambulatory surgery center operations. These challenges could significantly impact the company's revenue and profitability, leading to a negative outlook for its stock. In addition, the company's high levels of debt and low free cash flow generation add further concerns about its financial stability. Its recent underperformance compared to its past 5-year average and a lower projected valuation also contribute to the negative outlook.

Tenet Healthcare (THC) has been analyzed by 18 analysts, with a consensus rating of Buy. 39% of analysts recommend a Strong Buy, 56% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tenet Healthcare (THC) Forecast

Analysts have given Tenet Healthcare (THC) a Buy based on their latest research and market trends.

According to 18 analysts, Tenet Healthcare (THC) has a Buy consensus rating as of Aug 24, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $263.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $263.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tenet Healthcare (THC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.